Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 70 of 70 entries
View as:

CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03446976 Org: User:
Start: 02/21/18 End: 07/26/18 Due: 07/26/19

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02883452 Org: User:
Start: 09/29/16 End: 10/02/19 Due: 10/02/20

Demonstrate Efficacy and Safety of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01084876 Org: User:
Start: 06/30/10 End: 03/31/15 Due: 03/31/16

A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05568121 Org: User:
Start: 09/01/22 End: 10/27/22 Due: 10/27/23

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04512872 Org: User:
Start: 10/20/20 End: 05/04/21 Due: 05/04/22

PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02149121 Org: User:
Start: 08/31/14 End: 01/31/17 Due: 01/31/18

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04428814 Org: User:
Start: 08/03/20 End: 02/24/21 Due: 02/24/22

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Phase: N/A Priority: Normal
NCT ID: NCT03247673 Org: User:
Start: 08/07/17 End: 01/17/18 Due: 01/17/19

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04525079 Org: User:
Start: 07/18/20 End: 11/05/20 Due: 11/05/21

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT04418297 Org: User:
Start: 10/23/20 End: 11/22/22 Due: 11/22/23

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05725434 Org: User:
Start: 02/06/23 End: 07/31/23 Due: 07/31/24

Evaluate Safety, Efficacy and Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT01084863 Org: User:
Start: 02/28/10 End: 12/31/23 Due: 12/31/24

A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04602000 Org: User:
Start: 10/05/20 End: 10/20/21 Due: 10/20/22

To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)

Phase: N/A Priority: Normal
NCT ID: NCT06687928 Org: User:
Start: 03/26/25 End: 07/31/25 Due: 07/31/26

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05617183 Org: User:
Start: 11/15/22 End: 09/30/23 Due: 09/30/24

An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1

Phase: N/A Priority: Normal
NCT ID: NCT01571219 Org: User:
Start: 03/31/12 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin with Metformin

Phase: N/A Priority: Normal
NCT ID: NCT06571591 Org: User:
Start: 08/27/24 End: 05/31/26 Due: 05/31/27

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03676192 Org: User:
Start: 02/01/19 End: 09/19/23 Due: 09/19/24

A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

Phase: N/A Priority: Normal
NCT ID: NCT03511066 Org: User:
Start: 12/09/16 End: 06/15/18 Due: 06/15/19

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Phase: N/A Priority: Normal
NCT ID: NCT04205643 Org: User:
Start: 09/01/20 End: 07/11/23 Due: 07/11/24